70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container
Product details
- 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container
Company announcement
Baxter International Inc. is voluntarily recalling one lot of 70% Dextrose Injection due to the potential presence of stainless steel particles in the solution.
The impacted product was distributed from July 25, 2026 to July 28, 2026 to healthcare providers and distributors in Alabama, Georgia, and Tennessee.
As of August 25, 2026, Baxter has not received any reports of adverse events, injuries, or deaths related to this issue.
Risk:
Intravenous administration of 70% Dextrose Injection containing stainless steel particulate matter may lead to serious adverse health consequences. Particulate matter can cause blockage and clotting in blood vessels which can cut off blood flow to vital organs, lead to a life-threatening blood clot in the lungs (pulmonary embolism) and cause permanent organ damage or death. Additionally, these particles may cause local vein irritation, inflammatory reaction, aggravation of preexisting infections, and allergic reactions.
Impacted states: Nationwide
Products:
- 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container. Pharmacy Bulk Package, Not for Direct Infusion (UPC code(s): 0338071906)
Contact
For more information, call 888-229-0001.